| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
NEWS |
CLINICAL RESEARCH BOOST
United Kingdom Becomes the Cancer Clinical Trials Recruitment Capital of the World
| The first 10% of the full text of this article appears below. |
The more cancer patients that doctors recruit into clinical trials, the faster they can test new therapies. Yet recruitment remains abysmally lowexcept within the United Kingdom. Last year 32,000 patientsthe equivalent of 14% of Britain's annual cancer incidenceparticipated in cancer clinical trials.
"That's the highest rate of cancer clinical trial participation of any country in the world," said Richard Kaplan, M.D., associate director of Britain's National Cancer Research Network (NCRN). By contrast, less than 3% of all U.S. cancer patients participate in clinical trials, according to the National Cancer Institute.
Beginning in the early 1990s, the United Kingdom's Department of Health set out to overhaul cancer care. The National Health Service (NHS) not only established regional networks to ensure better access to care but also
The Backdrop
Recruitment in Practice
Barriers in the United States